Uncategorized

As an expert in global and strategic regulatory affairs, drug safety, and informed consent, it has been nothing short of devastating to observe how the pharmaceutical industry and the regulators have treated the injured over the last two years. Injured? Who are the injured? Am I writing about those injured in Ukraine, during Russia’s “Special …

OUT AT SEA…. Read More »

Those of us who work in the pharmaceutical industry, often state the mantra that we are seeking to address unmet medical needs.  We want to ensure that all patients are able to access our innovations.  Yet, at the same time, we want to ensure that we are compensated for our innovations. Without compensation, we simply …

skating on thin ice! Read More »